Actinic (Solar) Keratosis Treatment Market By Treatment type ( Photodynamic therapy, Topical treatments, Surgical procedures, Combination therapy ), By End-user ( Clinics, Hospitals, Oncology centers, Dermatology service centers ), Industry Trends, Estimation & Forecast, 2017 - 2025

April 2018

 Pages: 178

 ERC 6373


Actinic (solar) keratosis Treatment Market is expected to grow with a CAGR of 4.8% during the forecast period of 2018 to 2025.

Actinic keratosis or solar keratosis is a pre-cancerous skin disorder that is mainly caused due to the constant exposure of skin to UVB radiation. It is most prevalent in people above the age of 50 years, however, people at the age of 20 years are also prone to such skin disorders. The chances of actinic keratosis developing into a squamous cell skin cancer is at a rate of nearly 20%, if left untreated. People living near to the equator and having constant exposure to sun are the most likely to suffer from solar keratosis. According to the Skin Cancer Foundation, actinic keratosis is the most common type of pre-cancer disorder that affects nearly 58 million people in America. Moreover, approximately $3.3 billion are spent annually for treating melanoma skin cancer in the U.S. Owing to such notable statistics, the global actinic keratosis treatment market is expected to grow at a significant rate of 4.8% per year. In addition, prominent market players are focusing on merger & acquisitions, partnerships, product launch, and expansion, in order to uplift the global market and gain a competitive edge over their counterparts. However, the lack of awareness regarding actinic keratosis treatments and it’s carcinogenic developments if left untreated, are expected to hinder the growth of the market.

The report provides detailed qualitative and quantitative analysis of the global actinic (solar) keratosis treatment market. Market size and forecast in terms of value has been provided for the period - (2017 - 2025), for the segments namely treatment type, and end-user in each of the major regions of the world.

Global Actinic (Solar) Keratosis Treatment Market Player Analysis -

The report presents detailed analysis of major players operating in global actinic (solar) keratosis treatment market. Few of them include LEO Pharma Inc., DUSA Pharmaceuticals Inc., Clinuvel Pharmaceuticals Ltd, Valeant, Biofrontera AG, Galderma S.A., Perrigo Company plc, TOLMAR Pharmaceuticals, Inc., 3M Drug Delivery Systems, Athenex Inc, CritiTech Inc, Foamix Pharmaceuticals Ltd, G&E Herbal Biotechnology Co Ltd, Novartis AG, and Oncology Research International Ltd. Detailed coverage on these market players with information on their revenue from actinic (solar) keratosis treatment business, market share, gross margin and their growth strategies have been provided in the report.

Market Segmentation

Global actinic (solar) keratosis treatment market is segmented on the basis of treatment type, end-user, and geography. On the basis of treatment type, the market is categorized into photodynamic therapy, topical treatments, surgical procedures, and combination therapy. By end-user, the market is segmented into clinics, hospitals, oncology centers, dermatology service centers, others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Actinic (Solar) Keratosis Treatment Market Segmentation

By Treatment type
   • Photodynamic therapy
   • Topical treatments
             o Diclofenac gel
             o Imiquimod cream
             o Fluorouracil cream
             o Ingenol mebutate gel
             o Others
   • Surgical procedures
             o Curettage and desiccation
             o Laser surgery
             o Dermabrasion
             o Cryosurgery
   • Combination therapy

By End-user
   • Clinics
   • Hospitals
   • Oncology centers
   • Dermatology service centers
   • Others

By Geography
   • North America
             o U.S.
             o Canada
             o Mexico
   • Europe
             o U.K
             o France
             o Germany
             o Italy
             o Spain
             o Rest of Europe
   • Asia-Pacific
             o China
             o Japan
             o India
             o Korea
             o Rest of APAC
   • South America
             o Brazil
             o Rest of South America
   • Rest of the World
             o Middle East
             o Africa

Actinic (Solar) Keratosis Treatment Market Key Players

• LEO Pharma Inc.
• DUSA Pharmaceuticals Inc.
• Clinuvel Pharmaceuticals Ltd
• Valeant
• Biofrontera AG
• Galderma S.A.
• Perrigo Company plc
• TOLMAR Pharmaceuticals Inc.
• 3M Drug Delivery Systems
• Athenex Inc
• CritiTech Inc
• Foamix Pharmaceuticals Ltd
• G&E Herbal Biotechnology Co Ltd
• Novartis AG
• Oncology Research International Ltd

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Actinic (Solar) Keratosis Treatment Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Actinic (Solar) Keratosis Treatment Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!